Cognition Therapeutics In... (CGTX)

AI Score

Unlock

0.37

-0.00 (-0.86%)

At close: Apr 17, 2025, 3:59 PM

Cognition Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q1 2020
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Mar 31, 2020
Cash & Equivalents	25.01M	22.01M	28.53M	34.67M	29.92M	32.97M	37.19M	38.81M	41.56M	46.61M	45.77M	51.51M	54.72M	8.31M	11.3M	13.37M	5.19M	-2.89M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	5.78M
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	n/a	-1	-1	1.75M	1.43M	1.83M	1.73M	1.69M	1.28M	1.42M	n/a	3.21M	2.44M	372K	n/a	-2.89M
Receivables	2.69M	n/a	3.1M	861K	1.28M	1.64M	2.39M	1.61M	3.67M	2.53M	3.29M	2.79M	2.27M	1.15M	2.55M	2.32M	1.15M	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-3.29M	n/a	-1.8M	571K	766K	235K	544K	n/a
Other Current Assets	1.86M	3.37M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	4.97M	n/a	11K	10K	65K	27K	23K	n/a
Total Current Assets	29.55M	26.83M	33.55M	37.97M	34.22M	36.04M	41.55M	42.8M	47.65M	50.93M	50.74M	56.44M	58.99M	10.04M	14.68M	15.95M	6.91M	2.89M
Property-Plant & Equipment	679K	749K	819K	883K	941K	977K	984K	1.03M	1.05M	937K	784K	839K	145K	141K	165K	188K	211K	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	679K	749K	819K	883K	941K	2.73M	2.41M	2.86M	2.78M	2.63M	2.07M	2.26M	145K	3.35M	2.61M	560K	211K	-2.89M
Total Assets	30.23M	27.58M	34.37M	38.85M	35.16M	38.77M	43.96M	45.66M	50.42M	53.56M	52.81M	58.7M	59.14M	13.39M	17.29M	16.51M	7.12M	n/a
Account Payables	1.98M	1.9M	3.03M	2.64M	3.69M	2.86M	4.06M	3.12M	3.22M	8.09M	3.3M	4M	4.17M	2.77M	3.66M	3.19M	2M	n/a
Deferred Revenue	1.07M	1.12M	1.45M	1.58M	1.7M	910K	1.06M	1.65M	1.7M	1.6M	1.28M	1.32M	753K	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	279K	188K	184K	180K	174K	2K	217K	427K	n/a	114K	161K	150K	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	1.53M	9.51M	1.09M	790K	3.26M	919K	839K	480K	1.53M	1.17M	989K	1.79M	2.41M	1.59M	1.96M	429K	985K	n/a
Total Current Liabilities	11.14M	12.71M	10.92M	9.5M	10.17M	8.23M	7.91M	7.46M	7.79M	12.12M	6.82M	7.64M	7.86M	4.43M	6.22M	4.34M	3.25M	n/a
Long-Term Debt	n/a	n/a	440K	n/a	520K	565K	608K	n/a	n/a	603K	404K	446K	n/a	n/a	84.76M	12.69M	12.85M	n/a
Other Long-Term Liabilities	n/a	n/a	-440K	n/a	-520K	-565K	-608K	1.76M	n/a	-603K	-404K	-446K	n/a	95.68M	9.99M	67.34M	59.2M	n/a
Total Long-Term Liabilities	342K	392K	440K	488K	520K	1.62M	1.66M	2.42M	2.38M	2.12M	2.1M	2.31M	4.17M	95.68M	94.75M	80.03M	72.05M	n/a
Total Liabilities	11.48M	13.1M	11.36M	9.99M	10.69M	9.85M	9.57M	9.88M	10.18M	14.24M	8.91M	9.96M	7.86M	100.11M	100.97M	84.37M	75.3M	n/a
Total Debt	814K	580K	809K	668K	174K	737K	991K	1.24M	1.48M	717K	967K	1.4M	n/a	84.76M	84.76M	12.69M	12.85M	n/a
Common Stock	60K	41K	40K	40K	32K	30K	30K	29K	29K	24K	22K	22K	22K	1K	1K	2K	1K	n/a
Retained Earnings	-175.16M	-167.32M	-157.38M	-150.34M	-141.19M	-133.05M	-126.3M	-121.57M	-115.4M	-110.22M	-103.59M	-97.84M	-94M	-86.67M	-83.56M	-68M	-68.22M	n/a
Comprehensive Income	n/a	n/a	n/a	n/a	-195K	-196K	-196K	-195K	-199K	-201K	-200K	-197K	-198K	-196K	-193K	-192K	-187K	-58.42M
Shareholders Equity	18.75M	14.48M	23.01M	28.86M	24.47M	28.93M	34.39M	35.78M	40.25M	39.32M	43.9M	48.74M	51.27M	-86.72M	-83.68M	-67.85M	-68.18M	-5.5M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	5.78M